Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies

Cell. 2024 Jul 11;187(14):3726-3740.e43. doi: 10.1016/j.cell.2024.05.025. Epub 2024 Jun 10.

Abstract

Many growth factors and cytokines signal by binding to the extracellular domains of their receptors and driving association and transphosphorylation of the receptor intracellular tyrosine kinase domains, initiating downstream signaling cascades. To enable systematic exploration of how receptor valency and geometry affect signaling outcomes, we designed cyclic homo-oligomers with up to 8 subunits using repeat protein building blocks that can be modularly extended. By incorporating a de novo-designed fibroblast growth factor receptor (FGFR)-binding module into these scaffolds, we generated a series of synthetic signaling ligands that exhibit potent valency- and geometry-dependent Ca2+ release and mitogen-activated protein kinase (MAPK) pathway activation. The high specificity of the designed agonists reveals distinct roles for two FGFR splice variants in driving arterial endothelium and perivascular cell fates during early vascular development. Our designed modular assemblies should be broadly useful for unraveling the complexities of signaling in key developmental transitions and for developing future therapeutic applications.

Keywords: FGF signaling; binder design; cryo-EM; de novo protein design; endothelial cell differentiation; iPSCs; oligomeric scaffolds; vascular development.

MeSH terms

  • Animals
  • Calcium / metabolism
  • Cell Differentiation*
  • Fibroblast Growth Factors* / metabolism
  • Humans
  • Ligands
  • MAP Kinase Signaling System
  • Mice
  • Receptors, Fibroblast Growth Factor* / metabolism
  • Signal Transduction*

Substances

  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factors
  • Ligands
  • Calcium